1. Home
  2. JMSB vs OBIO Comparison

JMSB vs OBIO Comparison

Compare JMSB & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Marshall Bancorp Inc.

JMSB

John Marshall Bancorp Inc.

HOLD

Current Price

$23.25

Market Cap

308.2M

Sector

Finance

ML Signal

HOLD

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

HOLD

Current Price

$4.41

Market Cap

253.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JMSB
OBIO
Founded
2005
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
308.2M
253.9M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
JMSB
OBIO
Price
$23.25
$4.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$23.00
$14.25
AVG Volume (30 Days)
29.9K
176.4K
Earning Date
04-29-2026
05-11-2026
Dividend Yield
1.72%
N/A
EPS Growth
24.17
33.13
EPS
0.93
N/A
Revenue
N/A
$33,482,000.00
Revenue This Year
$17.09
N/A
Revenue Next Year
$10.03
$12.43
P/E Ratio
$25.01
N/A
Revenue Growth
N/A
1169.22
52 Week Low
$18.50
$2.20
52 Week High
$24.26
$5.42

Technical Indicators

Market Signals
Indicator
JMSB
OBIO
Relative Strength Index (RSI) 57.10 62.64
Support Level $20.72 $4.07
Resistance Level $24.26 $4.76
Average True Range (ATR) 0.57 0.20
MACD -0.05 0.05
Stochastic Oscillator 48.69 69.32

Price Performance

Historical Comparison
JMSB
OBIO

About JMSB John Marshall Bancorp Inc.

John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Share on Social Networks: